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Abstract 
Cytoplasmic adaptor MIG-10 plays a role in neuronal migration and process outgrowth in C. 
elegans. Data from a yeast-two hybrid assay indicate that MIG-10 interacts with ABI-1, a protein 
involved in regulation of actin polymerization and required for neuronal migration and outgrowth. To 
further characterize the interaction between MIG-10 and ABI-1, deletion mutants were created and co-
immunoprecipitation assays and western blots were performed. Preliminary results indicate that the C-
terminal SH3 region of ABI-1 is required for its interaction with MIG-10. 
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Introduction 
Developmental Cell Migration and Axonal Outgrowth 
 During human development, billions of neurons form a complex network within the brain. 
Between the 5th week and 5th month of pregnancy, neurogenesis can reach a rate of 250,000 neurons 
formed per minute. Within the cortex of the brain, progenitor, or precursor cells develop in the 
ventricular zone of the telencephalic vesicle of the brain and give rise to neurons and glia. From the 
ventricular zone cells migrate out towards the pia mater, a thin membrane near the surface of the brain, 
to form the six layers of the cortex. To begin this process, the cell extends a process out toward the pia 
and the cell nucleus moves toward the surface of the pia. There the DNA inside the nucleus is replicated. 
The nucleus, with two copies of the DNA, migrates back down into the ventricular zone. Lastly the cell 
retracts the process from the pia and the cell divides in two, producing daughter cells. Early in 
development, the two daughter cells stay in the ventricular zone and each continues the proliferation 
process. Later on in development, however, one of the daughter cells migrates into the cortex to form 
part of an upper cortical layer (Figure 1). This migration is very organized, with an inside-out mechanism 
in which the outermost cortical layer (VI) forms first, followed by layer V, etc. 
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Figure 1: Neuronal Migration from the Ventricular Zone to the Cortical Plate. During early 
development, neuroblasts migrate along radial glial processes from the ventricular zone towards the 
cortical plate.  Within the cortical plate, the neurons form six layers by an inside-out mechanism in 
which the first set of migrated neurons form the innermost layer (Bear et. al, 2007).   
The cell migration process is directed by radial glial cells. Daughter cells move along paths 
provided by radial glial cells from the ventricular zone to their destinations in the cortical layers. Once a 
cell reaches its final destination, it undergoes differentiation and forms connections to other cells that 
provide the nerve network in our brain. After differentiation occurs, cells are no longer able to divide.  
Differentiated neurons produce growth cones that develop into axons and dendrites (Figure 2). Growth 
cones include lamellipodia which are membranes on the tip of the cone that contain spiky filopodia, 
acting as legs to extend the growth cone (Bear et. al, 2007).   
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Figure 2: Growth Cone. Lamellipodia extend out from the axon as filopodia respond to guidance cues. 
(Bear et. al, 2007). 
Guidance cues are required to direct the growth cones to extend in a specific direction. 
Guidance cues can be attractive, guiding the axon towards it, or repulsive, pushing the axon away in an 
opposing direction. To direct the growth, guidance cues cause polarization of the growth cone by the 
accumulation of F-actin and microtubules on one side of the growth cone tip (Quinn and Wadsworth, 
2008). 
Improper cell migration and axonal outgrowth during brain development causes disorders 
associated with mental retardation. One such disorder is corpus callosum dysgenesis.  In patients with 
corpus callosum dysgenesis axons fail to make a connection between the left and right hemispheres. 
The connection can be partially or completely missing, causing mild to severe mental retardation (Engle, 
2010). Studying the normal process of cell migration and axonal outgrowth is the first step to 
determining what causes the improper migration and extensions of cells. After the cell migration 
process is further understood, the underlying causes of corpus callosum dysgenesis and similar disorders 
can be studied. This could one day lead to the creation of treatments and neuroregenerative therapies 
to ameliorate or eliminate the symptoms of neuronal migration disorders. 
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 This project aimed to improve our understanding of the developmental cell migration process in 
the model system C. elegans by characterizing interaction between two proteins, MIG-10 and ABI-1, 
known to be involved in cell migration and process outgrowth. The interactions between different 
domains of each protein were studied in vitro to determine which domains of MIG-10 and of ABI-1 are 
required for their interaction. Mutations affecting the interacting domains of either protein could 
disrupt the cell migration process and therefore may be a contributing factor in neuronal migration 
disorders. This project furthered our knowledge of the domains of MIG-10 and ABI-1 required for the 
two proteins’ interaction, thus indicating potential areas where mutations could cause disruption in the 
cell migration process.  
C. elegans as a Model System 
While guidance cues of axonal outgrowth have been well-studied, mechanisms that link 
guidance cues and the polarization of cell processes are not fully understood. One useful model system 
in which the cell migration process is more easily studied is the nematode species Caenorhabditis 
elegans. C. elegans has a much simpler nervous system than humans and other vertebrates, consisting 
of only 302 neurons (Brenner, 1974). C. elegans are also transparent, making in vivo studies of the 
worms easier with fluorescent tagging of cells (Chalfie, 1994).  
In C. elegans, the excretory cell and neurons, such as the HSN, ALM, and CAN, are useful in 
studying cell migration and process outgrowth. During development, the excretory cell body forms 
ventrally near the pharynx and extends multiple processes or canals dorsolaterally almost the length of 
the whole nematode. These processes then divide and extend anterior and posterior through C. elegans 
(Buechner, 2002). C. elegans embryos also have several neurons that undergo long-range migrations 
during development. These neurons, including HSN, ALM, and CAN, are easily visible under a microscope 
(Figure 3; Hedgecock et al., 1987). MIG-10 is one protein known to be involved in the cell migration 
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process of C. elegans. A null allele of the mig-10 gene, mig-10(ct41), resulted in truncation of the 
excretory canals and shortened migrations of the cell bodies of the HSN, AVM and CAN (Manser and 
Wood, 1990).   
 
Figure 3: ALM, CAN, and HSN Cell Migrations in C. elegans. A: Wild-type mig-10 in C. elegans; highlights 
the length of the wild-type excretory canal and migrations of the ALM, CAN, and HSN neurons. B: mig-
10(ct41), a null allele of mig-10 in C. elegans; the excretory canal is truncated compared to the wild-type 
and migrations of the ALM, CAN, and HSN are shortened (McShea, 2011). 
MIG-10 Structure and Function 
MIG-10 is a C. elegans ortholog of the vertebrate proteins RIAM and lamellipodin.  This family 
acts as cytoplasmic adaptor proteins which are involved in signal transduction processes (Lafuente et. al, 
2004; Krause et. al, 2004). MIG-10 expresses three transcripts which encode three isoforms, MIG-10A, 
MIG-10B and MIG-10C (Manser et. al, 1997; Figures 4 and 5). Each isoform contains a Ras-association 
domain (RA), pleckstrin homology domain (PH), and EVH1 binding sites (FP4) near the N and C termini. 
The RA domain is known to bind to CED-10/Rac-GTP complexes and the PH domain is known to bind to 
phosphatidylinosital (3,4) bisphosphate in the cell membrane (Quinn et. al, 2008). Data are consistent 
with the hypothesis that one or both of the FP4 regions of MIG-10 bind to UNC-34/Ena/VASP (Quinn, et. 
al, 2006; Chang et. al, 2006). The three isoforms only differ at the N termini, in length and sequence.  
To determine which isoforms of MIG-10 are sufficient for excretory canal outgrowth, fosmids 
(bacterial F-plasmids) expressing mig-10a and mig-10b transcripts were tested for their ability to rescue 
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excretory cell canal truncation in mig-10(ct41) mutants in vivo.  Fosmids expressing both mig-10a and 
mig-10b, but not mig-10c, transcripts displayed wild-type excretory canals in mig-10(ct41) mutants, 
indicating that mig-10c is not required for excretory canal outgrowth (Zhang, 2010; McShea, 2011). To 
test whether MIG-10 functions cell autonomously in the excretory cell, mig-10a or mig-10b cDNA was 
expressed specifically in the excretory cell. Both isoforms rescued excretory canal defects and no 
significant difference was found between excretory canal lengths in the presence of the MIG-10A or 
MIG-10B isoforms. These results show that MIG-10A or MIG-10B isoforms are sufficient for excretory 
cell outgrowth when expressed cell autonomously in the excretory cell. 
 
Figure 4: The Three Transcripts of Genomic mig-10 (Wormbase). Each transcript differs in the length 
and sequence of the 5’ exons.  The middle regions and 3’ exons are identical in both length and 
sequence of all three transcripts. Each transcript also has different upstream sequences which may act 
as promoters and therefore each transcript may be differentially regulated. mig-10c is denoted as 
(F10E9.6c) and has the longest N-terminus; it has not been shown to play a role in the cell migration 
process. mig-10a is denoted as (F10E9.6a) and mig-10b is denoted as (F10E9.6b). mig-10a is the main 
transcript which has been studied for protein interaction with abi-1 and is the transcript used in this 
project. 
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 Figure 5: The Three Protein Isoforms of MIG-10. The C terminus FP4 regions (yellow), Ras-association 
domain (RA) (orange) and Pleckstrin homology domain (PH) (red) are identical in the MIG-10A, MIG-10B, 
and MIG-10C isoforms. The RA and PH domains bind to CED-10/Rac-GTP and phosphatidylinosital (3,4) 
bisphosphate, respectively, during the cell migration process. The two FP4 regions with consensus 
sequence: (D/E)(F/L/W/Y)PPPPX(D/E)(D/E), are EVH1 binding sites, that putatively bind to UNC-
34/Ena/VASP. 13 PXXP regions are potential SH3 binding sites (blue) (Manser et al, 1997; Figure 
modified from McShea, 2011). 
MIG-10 Interacts with UNC-34 
UNC-34 is the only member of the Ena/VASP family of proteins found in C. elegans.  The EVH1 
domains of the Ena/VASP family of proteins bind to proline-rich EVH1 binding sites of MIG-
10/Lamellipodin, causing co-localization of UNC-34 with MIG-10 to the growth cone. Ena/VASP helps 
promote elongation of actin by bundling, prevention of G-actin capping of the barbed ends of F-actin, 
and debranching. Experiments with null unc-34 mutants resulted in a significant decrease in the number 
of filopodia in HSN growth cones (Chang et. al, 2006). Overexpression of UNC-34 however led to 
approximately triple the number of filopodia observed in the HSN neurons of the wild-type. Another 
experiment was conducted in which the null mig-10(ct41) mutant was expressed in addition to UNC-34 
overexpression. This resulted in suppression of the overexpressed UNC-34 phenotype. Combined, these 
results suggest that UNC-34 is required for the growth of filopodia and that MIG-10 is required upstream 
of UNC-34 (Chang et. al, 2006). 
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Axonal Outgrowth Signal Transduction Pathway Model 
 The current model of axonal outgrowth (Figure 6) involves MIG-10 localization to the cell 
membrane as an integral step. Overall, in response to guidance cues, CED-10/Rac-1 is activated, causing 
localization of MIG-10/Lamellipodin which then binds to UNC-34, resulting in regulated growth of the 
filopodia. This project focuses on creating a better understanding of how ABI-1 interacts with MIG-10 
during this process. 
During axon guidance, MIG-10 functions downstream from UNC-6/Netrin and SLT-1/Slit 
guidance cues (Quinn et al., 2006). UNC-6 serves as an attractive guidance cue for axonal outgrowth, 
secreted from the ventral side of the worm, while SLT-1 is a repellant guidance cue, secreted from the 
dorsal side.  Both guidance cues cause the AVM axon in C. elegans to move towards the ventral nerve 
cord. When MIG-10 is overexpressed in the absence of both guidance cues (slt-1; unc-6 double 
mutants), axonal outgrowth still occurs. However, the result is often a multipolar neuron in which the 
outgrowth appears less directed. When either guidance cue was wild-type, axonal outgrowth was 
rescued back to monopolarity. Furthermore, overexpression of MIG-10 with guidance cues causes 
enhancement of the axonal growth toward the ventral nerve cord (Quinn et. al, 2006; Chang et. al, 
2006). Adler also observed localization of MIG-10 to the ventral plasma membrane of the HSN neuron 
(Adler et. al, 2006). These results suggest that guidance cues lead to the localization of MIG-10 to a 
certain area of the cell to accomplish monopolar outgrowth of an axon. 
The current model is consistent with data indicating that MIG-10/Lamellipodin is localized 
through binding of its central RAPH (Ras-association and pleckstrin homology domains) region to 
activated CED-10/Rac-1. CED-10/Rac-1 is a G protein, activated by exchange of its GDP for GTP. In vitro 
binding assays were conducted in which MIG-10-RAPH::GFP binding to CED-10/Rac-1 was shown to be 
GTP dependent (Quinn et al., 2008). This result indicates that MIG-10 will only bind to activated CED-
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10/Rac-1. Activated CED-10/Rac-1 is required for the localization of MIG-10, which stimulates directed, 
monopolar outgrowth of the axon. CED-10 is likely to be activated locally by the presence of a guidance 
cue. Further studies found that the MIG-10 binding to Rac-GTP was conserved in lamellipodin but not in 
the RIAM ortholog (Quinn et. al, 2008).   
 The next step in axonal outgrowth in C. elegans is the binding of UNC-34 to MIG-10. Specifically, 
the first 118 amino acids of MIG-10A, containing a putative EVH1 binding site, have been shown to 
interact with UNC-34 (Quinn et. al, 2006). Likewise, MIG-10A amino acids 458-651, containing another 
putative EVH1 binding site, may also bind UNC-34 (Chang et. al, 2006). The current model, consistent 
with these data, suggests that one or both of the putative EVH1 binding sites (designated FP4) of 
localized MIG-10 bind to the EVH1 domain of UNC-34 protein. The model then indicates that UNC-34 
promotes the elongation of actin through debranching, anticapping and bundling. However, null unc-34 
mutants resulted in a less severe phenotype than that of null mig-10(ct41) mutants. This difference in 
phenotypic severity between null mutants suggests that MIG-10 may also be interacting with another 
protein that regulates actin elongation (Quinn, et. al, 2006). 
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Figure 6: Current Model of Actin Remodeling with MIG-10. A guidance cue signal contacts the cell and 
stimulates an exchange of GDP for GTP in the CED-10/RAC-GDP complex by a guanine nucleotide 
exchange factor (GEF) and phosphorylation of phosphatidylinositol phosphate (PIP) to 
phosphatidylinosital (3,4) bisphosphate (PI(3,4)P2). These activated molecules recruit MIG-10 to the 
plasma membrane, binding the PH domain of MIG-10 to PI(3,4)P2 and the RA domain of MIG-10 to the 
CED-10/Rac-GTP complex. MIG-10 localization to the plasma membrane recruits UNC-34 to the cell 
membrane via the FP4 regions of MIG-10. UNC-34 activity leads to elongation of F-actin in the direction 
of the guidance cue. ABI-1 is believed to bind to a region of MIG-10 and play a role in the cytoskeletal 
remodeling (McShea, 2011). 
MIG-10 and ABI-1 Interaction 
In order to explore the idea that MIG-10 may interact with another protein during the axonal 
outgrowth process, Gosselin and O’Toole (2008) conducted a yeast-two hybrid analysis. The yeast-two 
hybrid analysis involved using one of the MIG-10 isoforms, MIG-10A, to screen a C. elegans cDNA library 
for any proteins that can have interactions with MIG-10. The study found that ABI-1 was the strongest 
candidate for interaction with MIG-10 because it was isolated in six separate transformations of the 
cDNA library. The present study focuses on determining the domains of each protein required for 
interaction between MIG-10 and ABI-1, which are thought to be involved in actin remodeling during cell 
migration and axonal outgrowth in C. elegans.  
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ABI-1 Structure and Function 
 Abelson-interactor-1, or ABI-1, is a protein found in C. elegans downstream of Abelson tyrosine 
kinase (Abl). Vertebrates often have three Abi family members, similar to ABI-1 of C. elegans. The ABI 
family is involved in the binding of actin and regulation of actin dynamics (Echarri et. al, 2004). Near the 
N terminus ABI-1 contains a Q-SNARE domain next to an ABL-HHR domain (Schmidt et. al, 2009; Figure 
7). A wave-binding domain (WAB) which binds to the actin nucleator protein WAVE-1 is also located 
near the N terminus. A serine rich domain is in the middle of the protein. Several putative Src-homology 
3 (SH3) binding domains are toward the C terminus with an SH3 domain on the C terminus. One function 
of the SH3 domain is to bind to proline-rich regions of other proteins. The SH3 domain may be involved 
in interaction with MIG-10, since MIG-10 has several proline-rich regions (McShea, 2011). Thus, one goal 
of this project was to create deletion mutant constructs of ABI-1 to determine if the SH3 domain of AB1-
1 is required and sufficient for interaction with MIG-10. However, ABI-1 is known to be involved in 
several cellular processes from WAVE and Rac activation to Mena phosphorylation. Several of these 
processes could also be related to the function of ABI-1 and MIG-10 interaction. 
 
Figure 7: ABI-1 Structure. ABI-1 has a Wave Binding Domain (WAB) which overlaps with the Q-SNARE 
domain near the N terminus.  The Q-SNARE domain is followed by an ABL-HHR domain, a serine-rich 
middle region, SH3 binding sites and an SH3 domain on the C terminus. The SNARE domain is conserved 
in mammals and is required for binding to Syntaxin-1. The SH3 domain binds to proline-rich regions of 
other proteins and is thought to be involved in interaction with MIG-10 (modified from McShea, 2011). 
One process that ABI-1 is involved in is Rac activation. Rac is a GTPase protein that is involved in 
actin remodeling. To activate Ras to Rac, a GEF (Sos-1) exchanges a GDP for a GTP. This exchange takes 
place when a multi-protein complex forms between the GEF, ABI-1 and an actin barbed-end capping 
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protein, EPS8. Abi-1 association with EPS8 activates EPS8 which regulates the GEF activity and thus Rac 
activation. The EPS8/ABI-1 complex may also be involved in actin polymerization and other actin-related 
processes (Disanza et. al, 2005). 
ABI-1 also activates WAVE, an interactor of Arp2/3 complex. Arp2/3 is a protein complex which 
branches actin filaments. ARP2/3 complex alone cannot polymerize actin branching. Nucleation 
Promoting Factors (NPFs) such as the WASP and WAVE families activate the Arp2/3 complex. These NPFs 
relay signals from Cdc42 and Rac to the Arp2/3 complex. The NPFs are regulated through different 
processes. Inactivation of WAVE1 occurs through the formation of a complex with proteins Nap-1 and 
PIR121-Sra-1. WAVE2 is believed to be positively regulated by ABI-1. ABI-1 binds directly to WAVE2 
forming a WAVE-ABI1-Nap1-PIR121 complex which increases WAVE-mediated actin polymerization.  
Thus ABI-1 plays a regulatory role in WAVE-mediated actin polymerization (Disanza et. al, 2005). 
AB1-1 is also involved in some phosphorylation processes such as phosphorylation of the 
protein Mena. AB1-1 was determined to be an interactor with Mammalian Enabled (Mena), through a 
yeast-two hybrid system. Binding assays found that the proline rich domain of ABI-1 and the Ena/VASP 
homology 1 domain of Mena interact. AB1-1 promotes the tyrosine phosphorylation of Mena by c-Abl.  
It is suggested that AB1-1 regulates this phosphorylation by interacting with both Mena and c-Abl (Tani 
et. al, 2003). Lamellipodin, the vertebrate homolog of MIG-10, is also phosphorylated by Abl (Michael et. 
al, 2010). AB1-1 could interact with MIG-10 and/or UNC-34 similarly to its role in the Mena/c-Abl 
phosphorylation.  
Overall, ABI-1 localizes to the tips of lamellipodia and filopodia. In vertebrates, when the 
interaction between ABI-1 and WAVE-1 is interrupted, ABI-1 does not localize to the lamellipodia tips 
(Echarri et. al, 2004). In C. elegans, abi-1 mutants were used to study its function in the cells.  abi-
1(tm494) is a hypomorphic, or loss of function, allele of abi-1. In mutants homozygous for abi-1(tm494), 
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the excretory canals were truncated, similar to the mig-10(ct41) mutants (Schmidt, et. al, 2009). In 
addition, abi-1(RNAi) greatly enhanced the truncation of the excretory canal observed in mig-10 
mutants (Dubuke and Grant, 2009). abi-1(tm494) mutants also have defects in neuronal migration 
(McShea et. al, unpublished results). This evidence suggests that ABI-1 and MIG-10 have similar roles in 
the cell migration and outgrowth processes (McShea, 2011).  
Previous Research on MIG-10 and ABI-1 Interaction 
ABI-1 and MIG-10 both function in vivo in the excretory cell of C. elegans. McShea (2011) used a 
co-immunoprecipitation assay in D. melanogaster cells for further analysis of their interaction. V5 tags 
were used for MIG-10 and MIG-10 deletion mutants. GFP tags were used for ABI-1 and ABI-1 deletion 
mutants. The different deletion mutants analyzed are shown in Figure 8 below.  
 
Figure 8: ABI-1 and MIG-10 Deletion Mutants. Wild-type and mutant AB1-1 proteins were fused with 
GFP tags on the C terminus and wild-type and mutant MIG-10 proteins were fused with V5 tags on the C 
terminus. Wild-type and mutant proteins were analyzed for interaction using co-immunoprecipitation 
and Western blotting using anti-V5 antibodies (McShea, 2011). 
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Repeated co-immunoprecipitation of wild-type MIG-10A::V5 and mutant ABI-1(174-426)::GFP 
(missing the N terminus and most of the SH3 domain), followed by western blotting with anti-V5 
antibody resulted in minimal isolation of MIG-10A::V5, while wild-type MIG-10A::V5 and ABI-1::GFP 
showed higher levels of isolation, indicating first that co-immunoprecipitation of MIG-10A::V5 is specific 
to wild-type ABI-1::GFP (McShea, 2011). Furthermore, the N-terminus and/or the SH3 domain of ABI-1 
are required to mediate the interaction with MIG-10A. McShea then conducted co-immunoprecipitation 
of various deletion mutant constructs of both proteins. Preliminary results of western blots, using anti-
V5 antibody, showed that wild-type ABI-1::GFP and ABI-1(427-469)::GFP, containing most of the SH3 
region, were both able to co-immunoprecipitate MIG-10A::V5, MIG-10(RAPH)::V5, and MIG-10(C-
term)::V5. MIG-10 variants were not visibly isolated when co-expressed with the N terminus of ABI-1 
(ABI-1(1-173)::GFP). These preliminary results suggest that only the SH3 domain is required for 
interaction with MIG-10, however, these results were not able to be repeated.   
Since the yeast two hybrid and other experiments only focused on MIG-10A, MIG-10B was also 
tested for interaction with AB I-1. Co-immunoprecipitation of MIG-10B::V5 and ABI-1::GFP with western 
blotting using anti-V5 antibody resulted in isolation of MIG-10B::V5, indicating that MIG-10B can also 
interact with ABI-1 and therefore ABI-1 is not isoform specific to MIG-10. Since MIG-10A and MIG-10B 
differ in their N termini it is not likely that the N-termini interact with ABI-1 (McShea, 2011).   
Overall, preliminary results have indicated that the SH3 domain of ABI-1 and the RAPH and C-
term domains of MIG-10 are involved in the interaction of the two proteins. Based on these results, this 
project attempted to gather more data on the co-immunoprecipitation of ABI-1 and MIG-10 wild-type 
and deletion mutant proteins. 
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Project Goals 
 The goal of this project was to further characterize the interaction of MIG-10 and ABI-1 in the 
cell migration process. Specifically, the domains of ABI-1 and MIG-10 that are required for their 
interaction were studied. To accomplish this goal, ABI-1 and MIG-10 wild-type and deletion mutant 
proteins with fluorescent tags were studied in vitro. Based on McShea’s results, it appears that the SH3 
domain of ABI-1 may be required for the interaction between the two proteins. To further support this 
hypothesis, new abi-1 constructs were made using the Gateway Cloning System. Two constructs were 
created in which only the SH3 domain is missing (abi-1(1-415)::GFP and abi-1(1-426)::GFP) and one 
construct was made in which only the SH3 domain is present (abi-1(416-469)::GFP).  It was expected 
that interaction with MIG-10 would only be seen when the ABI-1 SH3 domain was present; however, the 
new constructs were not available in time for use in this project. Next, previous co-immunoprecipitation 
experiments by McShea were repeated in order to confirm interaction or lack of interaction between 
the wild-type and mutant proteins. Western blotting was used to detect the fluorescent tags and 
determine whether the 2nd protein was able to interact with the 1st protein. The results of this project 
will help further the understanding of the role of MIG-10 and ABI-1 in the cell migration process in C. 
elegans, which could lead to a better understanding of the homologs involved in the cell migration 
process of human development. 
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Materials and Methods 
Polymerase Chain Reaction 
PCR was conducted with 0.5 Units of Vent polymerase (New England Biolabs),  1X Thermopol 
buffer (New England Biolabs), 200 µM dNTPs, 0.4 µM of forward and reverse primers (Table 1), and 
approximately 4 ng of the wildtype template, per 25 µL reaction. PCR was run with an initial denaturing 
step at 94°C for 5 minutes followed by 35 cycles consisting of: 94°C denaturing for 30 seconds, 57°C 
annealing for 1 minute, and 72°C extension for 1 minute. 5 µL of each sample was run on a 0.8% agarose 
gel in 1X TAE buffer to determine if the PCR product was the approximate size expected. Once the PCR 
product was confirmed on the gel, the DNA was then used without further purification in the Gateway 
Cloning System. 
Table 1: PCR Primers Used to Make the abi-1 Deletion Mutant Constructs. Three new abi-1 deletion 
mutant constructs, abi-1(1-415), abi-1(1-426), and abi-1(416-469) were created using the primers 
below. 
Construct Name Forward Primer Forward Primer 
Sequence 
Reverse Primer Reverse Primer 
Sequence 
ABI-1(1-426) Abi_foratt 5” GGG GAC AAC 
TTT GTA CAA AAA 
AGT TGG AAA ATG 
AGT GTT AAT GAT 
CTT CAA GAG 3” 
Abi-1-174-426_R 5” GGG GAC AAC 
TTT GTA CAA GAA 
AGT TGG TGC AGC 
ATC ATA GTC GTA 
CAG G 3”  
 
ABI-1(1-415) Abi-1-N_foratt 5” GGG GAC AAC 
TTT GTA CAA AAA 
AGT TGG AAA ATG 
AGT GTT AAT GAT 
CTT CAA GAG CTC 
ATC 3” 
Abi-1-415_revatt 5” GGG GAC AAC 
TTT GTA CAA GAA 
AGT TGG TTC CAA 
ATA CTC GTT GGG 
CAT CCA TCC AGC 
AC 3” 
AB1-1(416-469) Abi-416_foratt 5” GGG GAC AAC 
TTT GTA CAA AAA 
AGT TGG AAA ATG 
AAA GTA CGG GTC 
CTG TAC GAC TAT 
G 3” 
Abi_revatt 5” GGG GAC AAC 
TTT GTA CAA GAA 
AGT TGG TAC TGG 
AAC TAC GTA GTT 
TCC AG 3”  
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Gateway Cloning System 
Using the Gateway Cloning System (Figure 9), 2 to 5.5 µL of PCR product, for approximately 150 
ng, was put into the BP reaction with 1.5 µL of pDONR vector for approximately 150 ng, 1 µL TE buffer, 
and 2 µL BP Clonase II enzyme (Invitrogen). The reaction proceeded overnight at 25°C.  5 µL of the 
resulting clone was then transformed into 50 µL of Max-Efficiency DH5α E. coli competent cells 
(Invitrogen) by incubating on ice for 30 minutes, then heat shocking the cells at 42°C for 30 seconds and 
adding 400 µL of SOC (Invitrogen). The transformation was incubated on a nutator at 37°C for one to 
three hours. Cells were then plated on LB plates containing 50 µg/mL Kanamycin and allowed to grow 
overnight at 37°C. Individual colonies on each plate were isolated and placed in 5 mL aliquots of LB with 
50 µg/mL Kanamycin. The QIAprep Spin Miniprep kit from Qiagen was then used to perform minipreps 
for each sample. 2 to 3 µL of each sample were removed for a restriction digest. 1 µL of restriction 
enzymes such as HindIII, BamHI, or BanII (New England Biolabs) with 1X BSA (New England Biolabs) as 
appropriate, 2 µL of corresponding 10X buffer (New England Biolabs), 2 µL of the sample DNA, and 
appropriate amount of dH2O, were combined for the 20 µL sample digest and incubated at 37°C for two 
hours. After the restriction digest, samples were placed in a 0.8% agarose gel and run for approximately 
1 hour at 100 V. 10 µL of approximately 50 ng/µL DNA samples were sent to Genewiz for sequencing, 
following Genewiz recommendations.   
Once the proper sequence was confirmed, 2 to 5.5 µL of sample, for approximately 150 ng, was 
put into the LR reaction. The LR reaction and subsequent DNA purification and sequencing were 
performed as detailed for the BP reaction with a few exceptions. The LR reaction required 150 ng of 
pUAST-GFP destination vector and 2 µL LR Clonase II enzyme (Invitrogen). High Efficiency DH5α E. coli 
chemically competent cells (New England Biolabs) were used. During the transformation, after heat-
shocking, cells were placed on ice for 5 minutes and then 950 µL of SOC was added. The transformation 
23 
 
was incubated on a nutator at 37°C for one hour. Cells were grown using Ampicillin selection (50 ug /ml) 
instead of Kanamycin. 
 
Figure 9: Gateway Cloning System (Invitrogen). First, wild-type or mutant PCR product with attB1.1 and 
attB2.2 sites and Donor Vector with attP1 and attP2 sites were mixed in solution. Recombination 
between the two sites was catalyzed by BP Clonase II to form an entry clone with the desired sequence.  
Recombination of the attB and attP sites formed attL sites in the entry clone. The second step used LR 
Clonase II to catalyze recombination between the entry clone attL1.1 and attL2.1 sites and the 
Destination Vector attR1 and attR2 sites, producing an expression clone with B1H and B2H sites, the 
desired coding sequence and a V5 or GFP tag (McShea, 2011).   
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Cell Culture and Transfection 
S3 Drosophila melanogaster cells were used to express the wild-type and mutant proteins. S3 
cells were fed 1X Schneider’s media (Gibco) with 12.5% FBS (Valley Biomedical) by volume and split 1:10 
every 3-4 days. Two days after a split, cells were diluted 1:10 with media. 2.0 mL of the diluted cells 
were placed into separate wells in a 6 well plate. After three more days, when cells were approximately 
80-95% confluent, transfection was started. Protein construct concentrations were diluted to 66.6 ng/µL 
with TE buffer. Arm::GAL4 was also diluted to 66.6 ng/µL with TE buffer. Using sterile technique in the 
tissue culture hood, old media was removed from each well and 2.0 mL of 1X PBS was added and 
allowed to sit for approximately 30 seconds. The PBS was removed and 1.6 mL of new media was placed 
in each well.  96 µL of EC buffer (Qiagen) was added to sterilized Eppendorf tubes. 2.0 µL of each 
expression construct and 2.0 to 4.0 µL of arm::GAL4 were added to individual tubes. 3.2 µL of Enhancer 
(Qiagen) was added to each tube, stirred, and incubated for 2-5 minutes. Then 10 µL of Effectene 
(Qiagen) was added to each tube, stirred gently, and incubated for 5-10 minutes. 600 µL of new media 
was then added to each tube. The solutions were then added to individual wells. Cells were harvested 3-
5 days after transfection. 
Co-Immunoprecipitation 
Cells from each co-transfection were resuspended in their existing media and 200 µL were 
removed for whole cell lysate (WCL) samples. The WCLs were centrifuged at approximately 4000 x g (or 
8000 rpm in a micro-centrifuge) for 5 minutes and the supernatant was removed. Pellets were 
resuspended in 100 µL of 1X Sample Buffer (12 mM Tris-HCl, pH 6.8; 5% glycerol; 0.4% SDS; 2.88 mM β-
mercaptoethanol; 0.02% bromophenol blue) and stored at 4°C overnight. The remainder of each co-
transfection was transferred to a 15 mL conical and centrifuged at 560 x g (or 2000 rpm) for 2 minutes at 
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4°C. The supernatant was removed and cells were lysed in 1 mL of Lysis buffer (containing 2X protease 
inhibitor (Roche) and 1X phosphatase inhibitor (1 mM sodium orthovanadate, 5 mM sodium 
pyrophosphate, 5 mM sodium fluoride) in EBC buffer (50 mM Tris, pH 8, 150 mM NaCl, 2 mM EDTA, 
0.5% NP-40)). The cells were vortexed until resuspended and incubated on ice for 15 minutes. After 
incubation, cell debris was pelleted by centrifugation at approximately 16,500 x g (or 14,000 rpm in a 
table-top centrifuge) for 10 minutes at 4°C. The supernatants were then transferred to new tubes and 1 
µL of mouse monoclonal anti-V5 antibody (Invitrogen) or 2 µL of rabbit polyclonal anti-GFP antibody 
(Clontech) were added to each sample. Samples were incubated on a nutator at 4°C for 30 minutes to 2 
hours. After incubation, if monoclonal anti-V5 antibody was used, 50 µL of Protein A magnetic beads 
(Miltenyi Biotec) were added or 100 µL were added if polyclonal anti-GFP antibody was used. Samples 
were incubated at 4°C for a minimum of 30 minutes. 
Magnetic columns (Miltenyi Biotec) were placed on a magnetic board and Eppendorf tubes were 
placed underneath to collect waste. Columns were rinsed with 200 µL of Lysis buffer. Cell lysates were 
then loaded onto the column. 200 µL of Lysis buffer was washed through the columns four times. 
Columns were then rinsed with 100 µL of Buffer X (50 mM Tris, pH 8.5, 250 mM NaCl, 2 mM EDTA and 
1% NP-40) followed by 100 µL of Final Wash Buffer (50mM Tris, pH 8). New collection tubes were placed 
under the columns and 20 µL of 2X Sample Buffer (preheated to 95°C for 5 minutes) was added to each 
column and incubated for 5 minutes. An additional 50 µL of 2X sample buffer was added to each column 
and co-immunoprecipitates were stored at -20°C overnight. 
Western Blotting 
10% resolving gels were prepared using 2.09 mL dH20, 1.67 mL Solution A (29.2% acrylamide, 
0.8% bis-acrylamide), 1.25 mL Solution B (1.5 M Tris-HCl, pH 8.8, 0.4% SDS, 21% (v/v) dH2O). 25 µL 10% 
APS and 2.5 µL TEMED were added just before pouring for a total of approximately 5 mL per gel. The 
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resolving gel was poured between two glass plates in a BioRad western apparatus and topped with ethyl 
alcohol to prevent evaporation. Once the resolving gel polymerized, the ethyl alcohol was removed and 
the stacking gel: 1.15 mL dH20, 0.33 mL Solution A, 0.5 mL Solution C (0.5 M Tris-HCl, pH 6.8, 0.4% SDS 
and 46% (v/v) dH2O) with 15 µL 10% APS and 2.5 µL of TEMED added just before pouring) was poured on 
top of the resolving gel. Once the stacking gel polymerized, the whole gel (with its plates) was immersed 
in 1X electrophoresis buffer and the wells were rinsed with buffer. Co-immunoprecipitates and WCLs 
were boiled at 100 °C for 5 minutes before loading onto the gels. 5 µL of EZ-Run Pre-stained Rec Protein 
Ladder (Fisher) or Novex Sharp Pre-Stained Protein Standard (Invitrogen) and 10 µL of each sample were 
loaded into individual wells. Gels were run at 20 mA for approximately 2-3 hours.  
A nitrocellulose/ECL membrane (GE Healthcare) and the transfer apparatus containing fiber 
pads and Whatman paper were prepared by soaking in 1X transfer buffer for approximately 15 minutes.  
The gel was then removed from the gel plates, the stacking gel was removed and the resolving gel was 
soaked in transfer buffer for 5 minutes. The gel was placed inside the transfer apparatus, on top of a 
fiber pad and Whatman paper, and then the membrane was laid over it with another Whatman paper 
and fiber pad on top. The protein transfer was run at 100V for 1 hour. 
After the transfer, a Pierce West Pico SuperSignal Kit was used to immunoblot the protein. The 
membrane was blocked in approximately 20 mL of 5% non-fat dry milk (NFDM) in TBST (20 mM Tris, pH 
7.6; 150 mM NaCl; 0.1% Tween-20) for 30-60 minutes and then rinsed in TBST. The membrane was 
incubated overnight at 4°C with primary antibody diluted with 10 mL of TBST in 1% NFDM for anti-V5 
antibody or 0.5% NFDM for anti-GFP antibody. Primary antibody was 1:5,000 diluted mouse monoclonal 
anti-V5 antibody (Invitrogen) for V5-tagged proteins or 1:1,000 mouse monoclonal anti-GFP antibody 
(Clontech) for GFP-tagged proteins. After incubation, the membrane was washed with approximately 20 
mL of TBST for 5 minutes, 5 times and then incubated with 1:40,000 diluted secondary antibody: HRP 
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conjugated goat anti-mouse antibody (Jackson ImmunoResearch Labs) for 1 hour at room temperature.  
The membrane was washed with approximately 20 mL of TBST for 5 minutes, 5 times and then placed 
on plastic wrap and covered with 1.5 mL substrate working solution (1:1 peroxide:luminol). The 
membrane was then placed in a sheet protector in an autoradiography cassette to transfer to a 
darkroom. Under red light, a piece of film was exposed to the membrane for an amount of time ranging 
from 30 seconds to 5 minutes. The film was then developed using a Kodak X-omat. 
 
 
 
 
 
 
 
 
 
 
28 
 
Results 
The main goal of this project was to determine which regions of ABI-1 are required for 
interaction with MIG-10. To achieve this goal several different methods were used. First, deletion 
mutant constructs of abi-1 were made using PCR and the Gateway Cloning System. The second step 
involved co-transfection and co-immunoprecipitation assays between different ABI-1 and MIG-10A 
constructs to allow for possible in vitro interaction of the proteins and deletion mutant constructs. 
Lastly, western blots were performed to detect if interaction occurred between two proteins. 
Deletion Mutant Constructs 
Several deletion mutant variants of MIG-10 and ABI-1 were previously created using the 
Gateway Cloning System. These variants include MIG-10(RAPH)::V5,  MIG-10(C-term)::V5, ABI-1(1-
173)::GFP, ABI-1(174-426)::GFP, and ABI-1(427-269)::GFP (Figure 8). Previous preliminary data are 
consistent with the model that the SH3 region of ABI-1 is required for interaction with MIG-10. 
Therefore this project aimed to make three new ABI-1 deletion mutant proteins (Figure 10). The first 
additional deletion mutant, ABI-1(1-415)::GFP would be used to determine if the SH3 domain is required 
for interaction with MIG-10 through lack of interaction without the SH3 domain. The second additional 
mutant, ABI-1: ABI-1(1-426)::GFP, contains a small portion of the SH3 domain and was made to be 
consistent with earlier experiments in which a slightly different boundary for the SH3 domain was 
defined. The third new deletion mutant construct containing only the SH3 region, ABI-1(416-469)::GFP, 
would be used to determine if the SH3 domain is sufficient for interaction with MIG-10.  
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Figure 10: ABI-1 Wild-type and Mutant Constructs. The full length wild-type abi-1 construct is shown at 
the top. abi-1 mutants were created missing a portion of the SH3 region (ABI-1(1-426)), missing the 
whole SH3 region (ABI-1(1-415)), and only containing the SH3 region (ABI-1(416-470)).  These mutants 
were made using PCR and the Gateway Cloning System. 
Creation of the new deletion mutant constructs began by PCR of ABI-1 with forward and reverse 
primers corresponding to respective ABI-1 sequences (Table 1). PCR products were confirmed by 
samples run on a 0.8% agarose gel. Each PCR product was recombined with a donor vector (containing 
the Kanamycin resistance gene) with BP Clonase II in the BP reaction of the Gateway Cloning System.  
The resulting entry clone was transformed into 50 µL of Max-Efficiency DH5α E. coli competent cells and 
then selected for by plating on LB plates containing 50 µg/mL Kanamycin. Individual colonies were 
grown up in 5 mL aliquots of LB with 50 µg/mL of Kanamycin. Minipreps were performed for each 
sample. Samples were then digested with different restriction enzymes and confirmed with a 0.8% 
agarose gel with 1kb DNA ladder (NEB) (Figures 11 and 12). The expected lengths of bands of abi-1(1-
426) with digestion by HindIII was 3732 bp and with digestion by BanII were 1851, 1623, 227 and 31 bp.  
Clone 1 did not show matching lengths and was not used further. Clones 3 and 5 show bands of the 
expected lengths. The expected lengths of bands of abi-1(1-415) with digestion by HindIII was 3699 bp 
ABI-1 
 
 
ABI-1(1-426) 
 
ABI-1(1-415) 
 
ABI-1(416-469) 
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and with digestion by BanII were 1851, 1590, 227 and 31 bp.  Clones 1, 3, and 5 showed bands of 
expected lengths.  
Construct  abi-1(1-426) L
A
D
D
E
R  
abi-1(1-415) 
Restriction Enzyme  HindIII   BanII  BanII  HindIII  
Clone 1 3 5 1 3 5  1 3 5 1 3 5 
Lane  1  2  3  4  5  6  7  8  9  10  11  12  13  
               
Ladder legend 
Figure 11: Gel Electrophoresis of abi-1(1-426) and abi-1(1-415) Entry Clone Minipreps. A restriction 
digest of clones 1, 3, and 5 of each construct was performed individually with HindIII and with BanII 
restriction enzymes.  abi-(1-426) clones 3 and 5 and abi-1(1-415) clones 1, 3, and 5 were confirmed. 
The expected lengths of bands of abi-1(416-469) with digestion by BanII were 1851 and 766 bp. Clones 
1-5 showed bands of expected lengths. The sequences of the appropriate clones were then confirmed 
by Genewiz. 
 
 
 
31 
 
Construct  abi-1(416-469) 
Restriction 
Enzyme 
LADDER BanII 
Clone 1 2 3 4 5 
Lane 1 2 3 4 5 6 
                              
Ladder legend  
Figure 12: Gel Electrophoresis of abi-1(416-469) Entry Clone Minipreps. A restriction digest of clones 1-
5 was performed with BanII. All five abi-1(416-469) were confirmed. 
Sequenced entry clones were recombined with GFP destination vector, pUASTaceGFP, (with an 
Ampicillin resistance gene) in the LR reaction with LR Clonase II. The resulting expression clones were 
then transformed and selected for by plating on LB plates containing 50 µg/mL Ampicillin. Individual 
colonies were grown up in 25-50 µg/mL Ampicillin and minipreps were performed. The resulting clones 
were digested with HindIII and run on a 0.8% agarose gel. Gel electrophoresis showed partial digests for 
each construct (Figure 13). Expected band lengths were 7285, 2993, 743, 44 and 24 bp for abi-1(1-
415)::GFP, 7318, 2993, 743, 44 and 24 bp for abi-1(1-426)::GFP, and 6946, 2993, 44 and 24 bp for abi-
1(416-469)::GFP. Bands seen between 3-4 kb for each clone are partial digests in which HindIII did not 
cut at all restriction sites. Each clone was sent out to Genewiz for sequencing and sequences were 
confirmed. 
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Construct  L 
A 
D 
D 
E 
R 
abi-1  
(1-415)::GFP 
abi-1  
(1-426)::GFP 
L 
A 
D 
D 
E 
R 
abi-1(416-
469)::GFP 
Restriction 
Enzyme 
HindIII HindIII 
Clone 1 2 1 1 
Lane 1 2 3 4 5 6 
                            
    Ladder legend  
Figure 13: Electrophoresis of abi-1(1-415)::GFP, abi-1(1-426)::GFP, and abi-1(416-469)::GFP Expression 
Clone Minipreps. Clones were digested with HindIII and run on a 0.8% agarose gel.  Each clone was only 
partially digested, however all clones were confirmed by sequencing. 
Protein Expression, Immunoprecipitation and Western Blotting  
In order to determine if there is interaction between ABI-1 and MIG-10 variants a series of 
assays involving protein expression, immunoprecipitation and western blotting were used (Figure 14). 
Wild-type and mutant constructs were co-transfected into an insect system. Arm::GAL4, which binds to 
an upstream activating sequence (UAS) upstream of the cloned gene fusions, was used to promote to 
the expression of the desired genes. Immunoprecipitation by anti-GFP antibody was then used to pull 
down the ABI-1::GFP variants. If interaction occurred between an ABI-1::GFP variant and a MIG-10::V5 
variant  (co-transfected in the same well) then the MIG-10::V5 variant should be co-immunoprecipitated 
with the ABI-1::GFP variant. Anti-GFP antibody was used during western blotting to show presence of 
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ABI-1::GFP brought down, while anti-V5 antibody was used to show presence, if interaction occurred, of 
MIG-10::V5 variants brought down. This system, with co-immunoprecipitation and whole cell lysate 
controls, allowed for further clarification of the domains of MIG-10 and ABI-1 involved in their 
interaction. 
 
Figure 14: Overview of Assays Involved in Determining in vitro Protein Interaction. Co-transfection 
with Arm::GAL4 was used to express abi-1 and mig-10 constructs. Co-immunoprecipitation was then 
performed with the protein variants and western blotting was used to detect presence of each protein 
(McShea, 2011). 
Transfection 
 Co-transfection was performed to introduce constructs into S3 Drosophila melanogaster cells. 
Since new deletion mutant constructs were not available in time, various mig-10 and abi-1 constructs 
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were co-transfected along with arm::GAL4 to drive expression. After 3-4 days transfections were 
checked for GFP expression using a fluorescence microscope. Only the GFP tag is fluorescent, therefore 
only transfections including abi-1 constructs with GFP tags were visible. Most transfections showed 
approximately 5-15% of cells glowing (Figure 15). 
 
Figure 15: Co-transfection of abi-1::GFP. Constructs encoding ABI-1 and MIG-10 wild-type and mutant 
proteins were co-transfected for expression in an insect cell system. Glowing cells indicate cells which 
are expressing GFP, indicating that ABI-1::GFP protein is being expressed. This picture represents a very 
efficient co-transfection. 
Co-Immunoprecipitation and Western Blotting 
Experiments with co-transfected cultures that showed >5% glowing cells were then harvested. 
200 µL of each well was removed for whole cell lysate samples that did not undergo co-
immunoprecipitation and were used as controls on western blots to show presence of proteins in the 
lysates. Co-immunoprecipitations were then performed on the remainder of the lysates and analyzed by 
western blotting. 
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Previously, McShea (2011) found that two regions of MIG-10, the RAPH region and the C-
terminus, may interact with ABI-1. In order to confirm which regions of MIG-10 interact with ABI-1, MIG-
10 variants MIG-10(RAPH)::V5 and MIG-10(C-term)::V5 were co-immunoprecipitated with wild-type ABI-
1::GFP. In addition, ABI-1::GFP and MIG-10A::V5 were co-immunoprecipitated as a positive control and 
ABI-1(174-426)::GFP and MIG-10A::V5 were co-immunoprecipitated as a negative control. ABI-1::GFP 
and MIG-10 variants were also co-immunoprecipitated singly to control for specificity of the co-
immunoprecipitation assay.  ABI-1 variants tagged with GFP were pulled down by anti-GFP antibody 
during co-immunoprecipitation. Co-immunoprecipitates probed with mouse monoclonal anti-GFP 
antibody show ABI-1 variants that were pulled down with anti-GFP antibody, visible in Figure 16 (IB: α-
GFP) below. Background bands in co-immunoprecipitation lanes of each experiment are seen at about 
50 kDa and are likely due to the magnetic Protein A Sepharose beads used in the co-
immunoprecipitation assay. Wild-type ABI-1::GFP is visible at approximately 80 kDa in lanes 1, 3, 6 and 
7, indicating that all ABI-1::GFP lysates were pulled down with anti-GFP antibody. ABI-1::GFP is also seen 
at 80 kDa in the whole cell lysates of the experimental co-transfections (lanes 8 and 9).  ABI-1(174-
426)::GFP is visible at approximately 56 kDa and in lane 2.  
The same co-immunoprecipitates were blotted and probed for V5 (Figure 16; IB: α-V5). Wild-
type MIG-10A::V5 is faintly visible at approximately 79 kDa in  the positive control lane 1, indicating that 
MIG-10A::V5 did interact with ABI-1::GFP. MIG-10A::V5 is not visible in the negative control (lane 2).  
MIG-10(RAPH)::V5 is visible at approximately 44 kDa in whole cell lysate lane 8 and MIG-10(C-term)::V5 
is visible at approximately 23 kDa in whole cell lysate lane 9. However, neither MIG-10(RAPH)::V5 or 
MIG-10(C-term)::V5 is visible in the experimental co-immunoprecipitation lanes (lanes 6 and 7 
respectively), indicating that neither MIG-10 variant had strong interaction with ABI-1::GFP. These data 
contradict previous results. Though control data was weak, these data suggest that neither the RAPH 
region nor the C-terminus of MIG-10 is sufficient for interaction with ABI-1.      
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MIG-10A::V5  +  +         
ABI-1::GFP  +   +    +  +  +  +  
ABI-1  
(174-426)::GFP  
 +         
MIG-10 
(RAPH)::V5  
   +   +   +   
MIG-10 
(C-term)::V5  
    +   +   +  
Lane  1  2  3  4  5  6  7  8  9  
 
 
Legend 
MIG-10A::V5  MIG-10(C-term)::V5  MIG-10(RAPH)::V5 
ABI-1::GFP  ABI-1(174-426)::GFP  Co-IP Background 
Figure 16: Western Blot of Mig-10 Variants Pulled Down With α-GFP and Probed for GFP and V5. 
Insect cells were co-transfected with mig-10 and abi-1 constructs as shown in the table.  Cells were 
immunoprecipitated with α-GFP antibody and probed with α-GFP antibody (upper blot) or α-V5 
antibody (lower blot). Whole cell lysates were run for each experimental well (right end of each blot). 
MIG-10 and ABI-1 variants are indicated by the colored arrows in the legend. 
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Previous preliminary results suggest that either the N-terminus or the C-terminal SH3 region of 
ABI-1 may be required for interaction with MIG-10 (McShea, 2011). In order to determine if the N-
terminus of ABI-1 interacts with MIG-10, ABI-1 variant ABI-1(1-173)::GFP was co-immunoprecipitated 
with wild-type MIG-10A::V5. ABI-1 variants tagged with GFP were pulled down by anti-GFP antibody 
during co-immunoprecipitation and probed with mouse monoclonal anti-GFP antibody (Figure 17; IB: α-
GFP).  ABI-1::GFP is visible in lane 1 (80 kDa) and ABI-1(174-426)::GFP is visible in lane 2 (56 kDa). The N 
terminus, ABI-1(1-173)::GFP, is 48 kDa and appears as a doublet with the 50 kDa background in lanes 3, 
5 and 6 and is visible in whole cell lysate lane 7 (corresponding to the lane 5 sample). ABI-1(1-173)::GFP 
is not seen in whole cell lysate lane 8 (corresponding to the lane 6 sample), however it appears the 
protein was present in the co-immunoprecipitate sample, as the band appears thicker and doublet-like 
compared to lanes with no ABI-1(1-173)::GFP, such as lane 4. The same co-immunoprecipitates were 
blotted and probed for V5 (Figure 17; IB: α-V5). MIG-10A::V5 is seen at 79 kDa in the positive control 
lane 1 and in whole cell lysate samples, lanes 7 and 8. MIG-10A::V5 is not visible in the negative control 
lane as expected and is also not visible in any of the experimental lanes (5 and 6) also containing ABI-
1(1-173)::GFP. These data are consistent with previous results and indicate that the N-terminal region of 
ABI-1 did not have strong interaction with MIG-10A. 
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MIG-10A::V5  + +  + + + + + 
ABI-1::GFP  +        
ABI-1  
(174-426)::GFP  
 +       
ABI-1  
(1-173)::GFP  
  +  + + + + 
Lane  1 2 3 4 5 6 7 8 
 
 
Legend 
MIG-10A::V5  ABI-1(1-173)::GFP 
ABI-1::GFP  ABI-1(174-426)::GFP  Co-IP Background 
Figure 17: Western Blot of ABI-1(1-173)::GFP Pulled Down With α-GFP and Probed for GFP and V5. 
Insect cells were co-transfected with mig-10 and abi-1 constructs as shown in the table. Cells were 
immunoprecipitated with α-GFP antibody and probed with α-GFP antibody (upper blot) or α-V5 
antibody (lower blot). Whole cell lysates were run for each experimental well (right end of each blot). 
MIG-10 and ABI-1 variants are indicated by the colored arrows in the legend. 
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Discussion 
This project set out to determine the domains required for interaction between MIG-10 and ABI-
1, two proteins important in neuronal migration and outgrowth.  Results from this project suggest that 
MIG-10(RAPH)::V5 and MIG-10(C-term)::V5 may not be sufficient for interaction with ABI-1::GFP (Figure 
16). These data contradict previous results in which MIG-10(RAPH)::V5 and MIG-10(C-term)::V5 each 
showed some interaction with ABI-1::GFP and ABI-1(426-469)::GFP (McShea, 2011). The RAPH region 
and C-terminus of MIG-10 both contain SH3 binding sites, making both regions logical candidates for 
interaction with the C-terminal SH3 binding site of ABI-1. New data from this project should not be used 
to make a conclusion about possible interaction of MIG-10 variants and ABI-1 because the positive 
control band was weak. It is possible that there was some interaction between the MIG-10 variants and 
ABI-1 which was not seen on the western blot due to weaker signals than the positive control. 
Ultimately, this experiment should be repeated for more concrete results.  
In addition, results from this project indicate that the N terminus of ABI-1, ABI-1(1-173)::GFP, 
containing WAB, Q-SNARE and ABL-HHR domains, is not sufficient for interaction with MIG-10A::V5 
(Figure 17). Although these results also contain a relatively weak positive control band, these data 
support previous research which suggested that ABI-1(1-173)::GFP was not sufficient for interaction with 
MIG-10A::V5 (McShea, 2011). Thus, previous and current data are consistent with the hypothesis that 
the N-terminus of ABI-1 is not sufficient for interaction with MIG-10. McShea had also previously 
determined that the middle domain of ABI-1, ABI-1(174-426)::GFP, containing serine rich regions and 
SH3 binding sites, was not sufficient for interaction with MIG-10A::V5. Data from McShea’s experiments 
suggest that the C-terminal SH3 domain of ABI-1 is required for interaction with MIG-10, and may 
interact with several domains of MIG-10 such as the RAPH and C-terminal regions. This hypothesis is 
logical biochemically because MIG-10 contains thirteen SH3 binding sites, across several domains of the 
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protein, each of which could potentially bind the SH3 region of ABI-1. However, this project was not 
specifically able to test this hypothesis due to time constraints.   
This project prepared new deletion mutant constructs in order to determine if the SH3 domain 
of ABI-1 is necessary and sufficient for MIG-10. Constructs, abi-1(1-415)::GFP and abi-1(1-426)::GFP, 
each missing a portion or the entire SH3 domain, were created to test the first half of the hypothesis. 
Constructs were not confirmed in time for use in this project; however, future co-immunoprecipitation 
experiments should be conducted with these new constructs to determine if the SH3 domain is 
necessary for interaction with MIG-10A::V5. A negative result, meaning a lack of binding between both 
constructs and MIG-10 would support the hypothesis that the SH3 domain of ABI-1 is required for 
interaction with MIG-10. The third new deletion mutant construct, abi-1(416-469)::GFP, containing only 
the C-terminal SH3 domain, was created to determine if the SH3 domain is sufficient for interaction with 
MIG-10A::V5. A positive result would support the hypothesis that the SH3 domain of ABI-1 is sufficient 
for interaction with MIG-10. 
When conducting future experiments, several technical aspects of assays used during this 
project should be considered. First, any additional cloning experiments should consider the age of E. coli 
cells, as older cells likely caused a great decrease in the efficiency of cloning during these experiments.  
Second, the health of the D. melanogaster S3 cells could affect transfection efficiency. During this 
project, cells were extending processes and dividing less frequently than normal which could possibly 
affect the uptake of desired genes into the cells during transfection. Future experiments may need to 
manipulate cell culture techniques (such as using conditioned media) to maintain a healthier cell culture. 
Next, co-immunoprecipitation and western assays could be manipulated for stronger results by trying 
different lysis buffers, storage time and temperatures (-20°C or 4°C) of co-immunoprecipitate samples, 
and film exposure levels. For example, buffers should be manipulated because buffers that are too 
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stringent may interrupt protein-protein interactions and cause a false result which can be interpreted as 
lack of interaction. If time and resources permit, whole cell lysates should also be performed on all MIG-
10 variants in an experiment, to confirm presence of MIG-10 variants in cases where no binding is seen, 
i.e. negative controls and negative experimental results.  
One pitfall of using deletion mutant proteins to determine the domains involved in interaction is 
the possibility of deleterious effects on protein folding. When a gene is manipulated, such as removing 
portions of the gene, it can result in an unstable protein or impact the folding of the overall protein. 
Protein shape is crucial for interaction with other proteins. If a protein folds differently due to deletion 
mutations, this may cause lack of interaction where interaction should occur and result in incorrect 
conclusions. Whole cell lysates can also be used to determine if there are severe differences in folding. If 
a protein does not run as expected on a gel, it is possible that the protein shape has been significantly 
altered. In the future, if altered protein-shape or instability appears to be impacting protein-protein 
interactions, then other types of mutations, particularly more targeted ones such as point mutations, 
should be considered.  A useful way to use point mutation would be to find an amino acid likely to be 
involved in the wild-type interaction and change the amino acid such that it may no longer interact with 
the other protein, without altering the protein shape. 
Once the domains required for in vitro interaction between MIG-10 and ABI-1 have been 
identified, further work should be done to determine the implications of this interaction in vivo. For 
example, it is not currently clear where abi-1 fits in the axonal outgrowth signal transduction pathway. 
Genetic analysis should be done to determine where abi-1 fits into the order of the pathway and what 
may occur downstream of abi-1. The axon guidance pathway may also involve other proteins in addition 
to ABI-1, as interaction with ABI-1 in vertebrates is known to lead to phosphorylation and activation of 
other proteins such as Mena, Rac, and WAVE. Once more is known about the C. elegans neuronal 
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migration and axon guidance pathways, scientists can use this information to help strengthen their 
understanding of how MIG-10 orthologs, Lamellipodin and RIAM, and vertebrate ABI proteins may 
interact in vertebrate neuronal migration and axon guidance pathways. Ultimately, this research will 
increase understanding of neuronal migration and axon guidance pathways in humans , which will in 
turn contribute to creation of neuroregenerative therapies to alleviate symptoms of neuronal migration 
disorders. 
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